Skip to main content
. 2023 Aug 25;46(9):1574–1586. doi: 10.2337/dci23-0030

Figure 4.

Figure 4

The timeline of the major therapeutic outcome trials focused on delaying DKD in patients with type 2 diabetes and CKD following the publication of RENAAL and IDNT (7379). MoAs, mechanisms of action.